en
Scientific article
English

Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial

Published inRadiotherapy and Oncology, vol. 139, p. 83-86
Publication date2019
Abstract

The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.

Keywords
  • Prostate cancer
  • Phase I/II trial
  • SBRT
  • Toxicity
  • Monotherapy
Citation (ISO format)
ZILLI, Thomas et al. Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial. In: Radiotherapy and Oncology, 2019, vol. 139, p. 83–86. doi: 10.1016/j.radonc.2019.07.018
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0167-8140
186views
0downloads

Technical informations

Creation04/28/2020 2:49:00 PM
First validation04/28/2020 2:49:00 PM
Update time03/15/2023 9:58:52 PM
Status update03/15/2023 9:58:51 PM
Last indexation01/17/2024 9:54:13 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack